BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14751132)

  • 1. Establishment of a HPV and p53-mutation-negative human cell line (CA) derived from a squamous carcinoma of the uterine cervix.
    Isaka K; Nishi H; Osakabe Y; Miyata M; Hokamura M; Nakada T; Itokazu O; Takayama M
    Gynecol Oncol; 2004 Jan; 92(1):15-21. PubMed ID: 14751132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a new HPV-negative squamous cell carcinoma cell line (Yumoto) from the human uterine cervix.
    Mitsuhashi A; Tanaka H; Tanaka N; Sugita M; Shirasawa H; Tokita H; Eda H; Sekiya S
    Gynecol Oncol; 1998 Sep; 70(3):339-47. PubMed ID: 9790785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a cell line (CUMC-3) derived from a human squamous carcinoma of the uterine cervix.
    Kim JW; Cho YH; Lyu MS; Lee CG; Jung JK; Kim SJ; Namkoong SE
    Gynecol Oncol; 1995 Apr; 57(1):47-60. PubMed ID: 7705700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CUMC-6, a new diploid human cell line derived from a squamous carcinoma of the uterine cervix.
    Kim JW; Lee CG; Cho YH; Kim JH; Kim SJ; Kim HK; Park TC; Song SK; Namkoong SE
    Gynecol Oncol; 1996 Aug; 62(2):230-40. PubMed ID: 8751555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of human uterine cervical epidermoid carcinoma cell line HHUS containing HPV 59 DNA.
    Ishiwata I; Tokieda Y; Iguchi M; Tamagawa T; Ishiwata C; Ishiwata I; Kiguchi K; Ishikawa H
    Hum Cell; 2004 Sep; 17(3):151-6. PubMed ID: 15859161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
    Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
    Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a new human cell line (EJ) derived from endometrial carcinoma.
    Isaka K; Nishi H; Nakada T; Osakabe Y; Hokamura M; Serizawa H; Ebihara Y; Takayama M
    Hum Cell; 2002 Dec; 15(4):200-6. PubMed ID: 12889855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix.
    Masumoto N; Fujii T; Ishikawa M; Saito M; Iwata T; Fukuchi T; Susumu N; Mukai M; Kubushiro K; Tsukazaki K; Nozawa S
    Hum Pathol; 2003 Aug; 34(8):778-83. PubMed ID: 14506638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
    Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
    Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
    Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment and characterization of TA-4 producing cell line (OMC-1) originating from a human squamous cell carcinoma of the uterine cervix].
    Ueda M; Maeda T; Yamada T; Miyawaki Y; Otsuki Y; Okamoto Y; Okamura S; Sano T; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1071-8. PubMed ID: 3746026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
    Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
    Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
    Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
    Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.
    Ngan HY; Tsao SW; Liu SS; Stanley M
    Genitourin Med; 1997 Feb; 73(1):54-8. PubMed ID: 9155557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a lymphoepithelial-like carcinoma cell line (HUUCLEC) derived from the human uterine cervix.
    Kiguchi K; Ishiwata I; Tokieda Y; Iguchi M; Ishiwata C; Iwata M; Ishizuka B; Yoshikawa H; Tachibana T; Hashimoto H; Ishikawa H
    Hum Cell; 2002 Jun; 15(2):97-102. PubMed ID: 12227504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.
    Razani B; Altschuler Y; Zhu L; Pestell RG; Mostov KE; Lisanti MP
    Biochemistry; 2000 Nov; 39(45):13916-24. PubMed ID: 11076533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
    Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
    Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.